Aim: The effects of low dose ultraviolet A‐1 (UVA‐1) phototherapy on different clinical stages
of morphea (localized scleroderma) were analyzed in this case study. Based on these data …

This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Background: Extracorporeal photochemotherapy (EP) is used for the treatment of cutaneous
T-cell lymphoma (CTCL), progressive systemic sclerosis (PSS), pemphigus vulgaris, and …

Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-
methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological …

Photopheresis is a leukapheresis-based therapy that utilizes 8-methoxypsoralen and
ultraviolet A irradiation. Photopheresis is currently available at approximately 150 medical …

BACKGROUND: Increased collagen synthesis, vascular damage, and T-lymphocytic
infiltration contribute to the development of systemic sclerosis. Preliminary studies revealed …

Extracorporeal photopheresis (ExP) has been shown to be an efficacious and well-tolerated
therapy in the treatment of cutaneous T-cell lymphoma (CTCL) and systemic sclerosis …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …

BACKGROUND AND OBJECTIVES: Standard or investigative immunosuppressive
therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only …

Chronic graft-versus-host disease (GVHD) is almost always associated with skin diseases
appearing either as lichenoid GVHD, sclerodermatous GVHD (sGVHD) or as eosinophilic …